LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
64 hedge funds and large institutions have $82.1M invested in La Jolla Pharmaceutical Company in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less call options, than puts
Call options by funds: $235K | Put options by funds: $375K
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
Holders
64
Holding in Top 10
2
Calls
$235K
Puts
$375K
Top Buyers
| 1 | +$2.86M | |
| 2 | +$927K | |
| 3 | +$915K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$563K |
| 5 |
Goldman Sachs
New York
|
+$379K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$985K | |
| 3 | -$789K | |
| 4 |
Two Sigma Investments
New York
|
-$363K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$356K |